A Comparative Analysis of Current Lipid Treatment Guidelines: Nothing Stands Still

Anjan Tibrewala, Arif Jivan, William J. Oetgen, Neil J. Stone*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations


Lipid treatment guidelines have continued to evolve as new evidence emerges. We sought to review similarities and differences of 5 lipid treatment guidelines from the American College of Cardiology/American Heart Association, Canadian Cardiovascular Society, European Society for Cardiology/European Atherosclerosis Society, U.S. Preventive Services Task Force, and U.S. Veterans Affairs/Department of Defense. All guidelines utilize rigorous evidentiary review, highlight statin therapy for primary and secondary prevention of atherosclerotic cardiovascular disease, and emphasize a clinician-patient risk discussion. However, there are differences in statin intensities, use of risk estimators, treatment of specific patient subgroups, and consideration of safety concerns. Clinicians should understand these similarities and differences in current and future guideline recommendations when considering if and how to treat their patients with statin therapy.

Original languageEnglish (US)
Pages (from-to)794-799
Number of pages6
JournalJournal of the American College of Cardiology
Issue number7
StatePublished - Feb 20 2018


  • atherosclerotic cardiovascular disease
  • cholesterol
  • lipid
  • primary prevention
  • secondary prevention
  • statin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'A Comparative Analysis of Current Lipid Treatment Guidelines: Nothing Stands Still'. Together they form a unique fingerprint.

Cite this